Opthamology @Point of Care Podcasts
In this episode, our faculty take a deeper dive into their discussion of treatments of neovascular AMD, including anti-VEGF agents and some of the newer agents, including a bispecific antibody that inhibits both VEGF and Ang2. Visit www.morningcommutepodcast.com/AMD2 [http://www.morningcommutepodcast.com/AMD2] to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit
6 episodes
Comments
0Be the first to comment
Sign up now and become a member of the Opthamology @Point of Care Podcasts community!